Ansell Limited Acquires a Minority Share in Yulex Corporation

Melbourne, Australia, November 28 (ots/PRNewswire) -

Ansell Limited (ANN.AX), a global leader in protection solutions,
today announced it has purchased a minority share of Yulex
Corporation, a manufacturer of biopolymers derived from guayule. The
investment is not expected to have any material impact on Ansell's
earnings per share in Fiscal Years 2012 and 2013.

Further, Ansell and Yulex executed an exclusive agreement for the
global development, manufacturing and distribution rights for medical
gloves, personal protective equipment gloves, and condoms made of
guayule latex.

Guayule (Parthenium argentatum) is a commercial crop (a small
evergreen shrub) and the only rubber-producing species other than the
Brazilian rubber tree (Hevea brasiliensis) that has been used for
latex production on a commercial scale. Extensive scientific research
suggests that guayule latex does not produce allergic reactions with
natural rubber latex sensitive individuals.

Magnus Nicolin, CEO of Ansell Limited commented "Our agreements
with Yulex are an important step in our strategy to accelerate the
development of new innovative products while reducing our usage of
rubber tree latex."

"We are pleased to be partnering with Ansell," said Yulex
Corporation CEO, Jeff Martin. "Our collaboration will advance the
acceptance of guayule natural rubber as a U.S. biobased alternative
for natural rubber and petroleum-based rubber products. We are
committed to developing 'green' renewable technologies for consumer
and healthcare markets"

About Ansell

Ansell is a world leader in providing superior health and safety
protection solutions that enhance human well being. With operations
in the North America, Latin America, EMEA and Asia, Ansell employs
more than 10,000 people worldwide and holds leading positions in the
industrial and medical gloves market, as well as in the sexual health
and well being category worldwide. Ansell operates in four main
business segments: Medical Solutions, Industrial Solutions, New
Verticals, and Sexual Wellness. Information on Ansell and its
products can be found at http://www.ansell.com.

About Yulex Corporation

Yulex has developed a portfolio of biobased elastomer products
derived from the U.S. grown guayule plant. The technological
innovation is designed to replace traditional tropical or petroleum
based rubber for consumer, industrial and medical markets, with the
residual agricultural materials utilized as a feedstock for
bioenergy. Yulex collaborates with customers to develop and market
highly differentiated premium performance products in an ecologically
responsible, sustainable manner. Yulex Corporation is primarily owned
by Argonaut Private Equity. More information can be found at
http://www.yulex.com

ots Originaltext: Ansell Healthcare Europe nv
Im Internet recherchierbar: http://www.presseportal.de

Contact:
For more information: Ansell Media Relations, Wouter Piepers,
G.C.- Ansell, Tel: +322-5287400 / +32-478335632,
wpiepers@eu.ansell.com; EU
Claire Keane, Edelman,
Tel:+353-16789333, Claire.keane@edelman.com; AU Peter Brookes,
Citadel,
Tel :+61-0407-911-389, pbrookes@citadelpr.com.au; Ansell Investor
Relations, David Graham, I.R. -Ansell, Tel: +613-9270-7215 /
+61-4011-40749, dgraham@ap.ansell.com